Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Debt / NOTE 1.000%11/1
-
Market price (% of par)
-
91.13%
-
Total 13F principal
-
$461,458,000
-
Principal change
-
+$37,263,000
-
Total reported market value
-
$421,344,894
-
Number of holders
-
39
-
Value change
-
+$26,191,596
-
Number of buys
-
21
-
Number of sells
-
17
Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q1 2016
As of 31 Mar 2016,
ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 was held by
39 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$461,458,000
in principal (par value) of the bond.
The largest 10 bondholders included
ADVENT CAPITAL MANAGEMENT /DE/, CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, JPMORGAN CHASE & CO, CALAMOS ADVISORS LLC, UBS ASSET MANAGEMENT AMERICAS INC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, LAZARD ASSET MANAGEMENT LLC, Invesco Ltd., and SONORA INVESTMENT MANAGEMENT, LLC.
This page lists
39
institutional bondholders reporting positions
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.